Mrv1909 02092020232D 17 17 0 0 0 0 999 V2000 1.0717 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 -0.8250 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.3572 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 -0.4125 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.0717 -0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3572 0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.0717 0.8250 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.0717 1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7861 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5006 0.8250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3572 0.4125 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.3572 1.2374 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.7861 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5006 0.4125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0717 0.4125 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.0717 1.2374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 16 1 1 0 0 0 0 16 6 1 0 0 0 0 1 2 1 0 0 0 0 2 3 1 1 0 0 0 2 4 1 0 0 0 0 4 5 1 1 0 0 0 4 11 1 0 0 0 0 11 6 1 0 0 0 0 11 7 1 0 0 0 0 7 8 1 1 0 0 0 7 9 1 0 0 0 0 9 10 1 0 0 0 0 11 12 1 6 0 0 0 16 14 1 0 0 0 0 14 13 2 0 0 0 0 14 15 1 0 0 0 0 16 17 1 6 0 0 0 M END > DB03548 > drugbank > [H][C@@]1(O[C@](O)(C[C@@H](O)[C@H]1O)C(O)=O)[C@H](O)CO > InChI=1S/C8H14O8/c9-2-4(11)6-5(12)3(10)1-8(15,16-6)7(13)14/h3-6,9-12,15H,1-2H2,(H,13,14)/t3-,4-,5-,6-,8-/m1/s1 > NNLZBVFSCVTSLA-HXUQBWEZSA-N > C8H14O8 > 238.192 > 238.068867424 > 8 > 30 > -1.0000014330218978 > 21.105079946321723 > 1 > 6 > 0 > 0 > (2R,4R,5R,6R)-6-[(1R)-1,2-dihydroxyethyl]-2,4,5-trihydroxyoxane-2-carboxylic acid > -2.81 > -2.6455673833333333 > 0.41 > 0 > -1 > 1 > -1 > 11.111294812920784 > 2.890134275479364 > -2.9745201549719393 > 147.68 > 46.717600000000004 > 3 > 0 > 6.12e+02 g/l > mozenavir > 0 > DB03548 > EXPT01967 > experimental > 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid > 3-deoxy-α-D-manno-oct-2-ulopyranosonic acid; α-2-keto-3-deoxyoctulosonic acid pyranose; α-Kdo; α-KDop $$$$